Mega LifeSciences, also known as Mega We Care, is a prominent player in the healthcare industry, headquartered in Thailand. Founded in 1985, the company has established a strong presence across Southeast Asia, with significant operations in countries such as Myanmar, Vietnam, and Malaysia. Specialising in the development and distribution of high-quality pharmaceuticals, dietary supplements, and herbal products, Mega LifeSciences is recognised for its commitment to innovation and quality. The company’s unique formulations and extensive product range cater to diverse health needs, setting it apart in a competitive market. With a focus on enhancing health and well-being, Mega LifeSciences has achieved notable milestones, including numerous certifications and awards that underscore its market position as a trusted provider in the healthcare sector.
How does Mega LifeSciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Mega LifeSciences's score of 33 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Mega LifeSciences reported total carbon emissions of approximately 9,000,980 kg CO2e. This figure includes 1,808,570 kg CO2e from Scope 1 emissions, 6,752,890 kg CO2e from Scope 2 emissions, and 439,530 kg CO2e from Scope 3 emissions. This represents a significant increase from 2022, when the company recorded total emissions of about 627,413,270 kg CO2e, with Scope 1 emissions at 633,276,080 kg CO2e, Scope 2 at 5,504,540 kg CO2e, and Scope 3 at 358,280 kg CO2e. Despite the increase in emissions, there are currently no publicly disclosed reduction targets or climate pledges from Mega LifeSciences. The company has not outlined specific initiatives aimed at reducing its carbon footprint, which places it in a challenging position within the industry as climate commitments become increasingly important.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | |
---|---|---|
Scope 1 | 633,276,080 | 0,000,000 |
Scope 2 | 5,504,540 | 0,000,000 |
Scope 3 | 358,280 | 000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mega LifeSciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.